Intervention: Rivaroxaban, or Edoxaban , or Apixaban , or Dabigatran
Found 55 matching trials
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
PHASE4
The study goal is to determine the clinical benefit of percutaneous cathete...
Status
Completed
Location
Charité Universitätsmedizin Berlin, Klinik für Kardiologie, Angiologie und Intensivmedizin, Deutsches Herzzentrum der Charité, Campus Benjamin Franklin (CBF)
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
NA
PAUSE 2 study is a prospective, open-label, blinded-endpoint non-inferiorit...